These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12531355)

  • 21. Ag85B of mycobacteria elicits effective CTL responses through activation of robust Th1 immunity as a novel adjuvant in DNA vaccine.
    Takamura S; Matsuo K; Takebe Y; Yasutomi Y
    J Immunol; 2005 Aug; 175(4):2541-7. PubMed ID: 16081827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein.
    Peet NM; McKeating JA; de Souza JB; Roitt IM; Delves PJ; Lund T
    Virology; 1998 Nov; 251(1):59-70. PubMed ID: 9813203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prime-boost immunization schedules based on influenza virus and vaccinia virus vectors potentiate cellular immune responses against human immunodeficiency virus Env protein systemically and in the genitorectal draining lymph nodes.
    Gherardi MM; Nájera JL; Pérez-Jiménez E; Guerra S; García-Sastre A; Esteban M
    J Virol; 2003 Jun; 77(12):7048-57. PubMed ID: 12768024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of the humoral and cellular immune responses against hepatitis C virus core induced by DNA-based immunization.
    Hu GJ; Wang RY; Han DS; Alter HJ; Shih JW
    Vaccine; 1999 Aug; 17(23-24):3160-70. PubMed ID: 10462252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced CD8+ T cell immune response against a V3 loop multi-epitope polypeptide (TAB13) of HIV-1 Env after priming with purified fusion protein and booster with modified vaccinia virus Ankara (MVA-TAB) recombinant: a comparison of humoral and cellular immune responses with the vaccinia virus Western Reserve (WR) vector.
    Gómez CE; Rodríguez D; Rodríguez JR; Abaitua F; Duarte C; Esteban M
    Vaccine; 2001 Dec; 20(5-6):961-71. PubMed ID: 11738764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polygene DNA vaccine induces a high level of protective effect against HIV-vaccinia virus challenge in mice.
    Shinoda K; Xin KQ; Jounai N; Kojima Y; Tamura Y; Okada E; Kawamoto S; Okuda K; Klinman D; Okuda K
    Vaccine; 2004 Sep; 22(27-28):3676-90. PubMed ID: 15315847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Shaping T cell - B cell collaboration in the response to human immunodeficiency virus type 1 envelope glycoprotein gp120 by peptide priming.
    Steede NK; Rust BJ; Hossain MM; Freytag LC; Robinson JE; Landry SJ
    PLoS One; 2013; 8(6):e65748. PubMed ID: 23776539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A qualitative progression in HIV type 1 glycoprotein 120-specific cytotoxic cellular and humoral immune responses in mice receiving a DNA-based glycoprotein 120 vaccine.
    Fuller DH; Haynes JR
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1433-41. PubMed ID: 7888198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluating strategies to enhance the anti-tumor immune response to a carbohydrate mimetic peptide vaccine.
    Monzavi-Karbassi B; Pashov A; Jousheghany F; Artaud C; Kieber-Emmons T
    Int J Mol Med; 2006 Jun; 17(6):1045-52. PubMed ID: 16685414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancement of immunoglobulin G2a and cytotoxic T-lymphocyte responses by a booster immunization with recombinant hepatitis C virus E2 protein in E2 DNA-primed mice.
    Song MK; Lee SW; Suh YS; Lee KJ; Sung YC
    J Virol; 2000 Mar; 74(6):2920-5. PubMed ID: 10684312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of Heterologous Tier 2 HIV-1-Neutralizing and Cross-Reactive V1/V2-Specific Antibodies in Rabbits by Prime-Boost Immunization.
    Townsley S; Mohamed Z; Guo W; McKenna J; Cleveland B; LaBranche C; Beaumont D; Shen X; Yates NL; Pinter A; Tomaras GD; Ferrari G; Montefiori DC; Hu SL
    J Virol; 2016 Oct; 90(19):8644-60. PubMed ID: 27440894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit.
    Barnett SW; Rajasekar S; Legg H; Doe B; Fuller DH; Haynes JR; Walker CM; Steimer KS
    Vaccine; 1997 Jun; 15(8):869-73. PubMed ID: 9234536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of cellular and humoral immune responses to a multiepitopic HIV-1 DNA vaccine by interleukin-18 DNA immunization/viral protein boost.
    Billaut-Mulot O; Idziorek T; Loyens M; Capron A; Bahr GM
    Vaccine; 2001 Apr; 19(20-22):2803-11. PubMed ID: 11282190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improvement in T helper 1-related immune responses in BALB/c mice immunized with an HIV-1 gag plasmid combined with a chimeric plasmid encoding interleukin-18 and flagellin.
    Chen YL; Chen YS; Hung YC; Liu PJ; Tasi HY; Ni WF; Hseuh PT; Lin HH
    Microbiol Immunol; 2015 Aug; 59(8):483-94. PubMed ID: 26094825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced immunogenicity of a human immunodeficiency virus type 1 env DNA vaccine by manipulating N-glycosylation signals. Effects of elimination of the V3 N306 glycan.
    Bolmstedt A; Hinkula J; Rowcliffe E; Biller M; Wahren B; Olofsson S
    Vaccine; 2001 Nov; 20(3-4):397-405. PubMed ID: 11672902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant action of murine IL-2/Ig plasmid after intramuscular immunization with Indian HIV-1 subtype C recombinant env.gp 120 construct.
    Aggarwal P; Kumar S; Vajpayee M; Seth P
    Viral Immunol; 2005; 18(4):649-56. PubMed ID: 16359231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long lived multi-isotype anti-HIV antibody responses following a prime-double boost immunization strategy.
    Stambas J; Brown SA; Gutierrez A; Sealy R; Yue W; Jones B; Lockey TD; Zirkel A; Freiden P; Brown B; Surman S; Coleclough C; Slobod KS; Doherty PC; Hurwitz JL
    Vaccine; 2005 Mar; 23(19):2454-64. PubMed ID: 15752831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunization with Th-CTL fusion peptide and cytosine-phosphate-guanine DNA in transgenic HLA-A2 mice induces recognition of HIV-infected T cells and clears vaccinia virus challenge.
    Daftarian P; Ali S; Sharan R; Lacey SF; La Rosa C; Longmate J; Buck C; Siliciano RF; Diamond DJ
    J Immunol; 2003 Oct; 171(8):4028-39. PubMed ID: 14530323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunogenicity of HIV type 1 gp120 CD4 binding site phage mimotopes.
    Dorgham K; Dogan I; Bitton N; Parizot C; Cardona V; Debré P; Hartley O; Gorochov G
    AIDS Res Hum Retroviruses; 2005 Jan; 21(1):82-92. PubMed ID: 15665647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of gene-gun-mediated Th2 immunity to hepatitis B surface antigen by bacterial CpG motifs or IL-12.
    Schirmbeck R; Reimann J
    Intervirology; 2001; 44(2-3):115-23. PubMed ID: 11509872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.